BMS 6072 (Glucovance 1.25 mg / 250 mg)
Generic Name: glyburide/metformin
Pill with imprint BMS 6072 is Yellow, Elliptical/Oval and has been identified as Glucovance 1.25 mg / 250 mg. It is supplied by Bristol-Myers Squibb.
Glucovance is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Glucovance 1.25 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BMS 6072
Glucovance
- Generic Name
- glyburide/metformin
- Imprint
- BMS 6072
- Strength
- 1.25 mg / 250 mg
- Color
- Yellow
- Size
- 13.00 mm
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb
- Inactive Ingredients
-
microcrystalline cellulose,
povidone,
croscarmellose sodium,
magnesium stearate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00087-6072 (Discontinued) | Bristol-Myers Squibb Company |
| 54868-4906 (Discontinued) | Physicians Total Care Inc. (repackager) |
More about Glucovance (glyburide / metformin)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (2)
- Drug images
- En español
- Drug class: antidiabetic combinations
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.